Dose finding for a safe and efficacious combination of chloroquine (CQ) and methylene blue in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso
Completed
- Conditions
- Malariancomplicated falciparum malariaInfections and Infestations
- Registration Number
- ISRCTN36731786
- Lead Sponsor
- DSM Fine Chemicals (Austria)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 576
Inclusion Criteria
Children (6-59 months), with uncomplicated falciparum malaria, =2000 Plasmodium falciparum, Burkinabe nationality
Exclusion Criteria
1. Complicated or severe malaria
2. Hospitalised before for the same trial
3. Any apparent significant disease other than malaria
4. Hyperparasitaemia (>100,000/µl)
5. Patient is included in another trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method